Richard G. Lalonde - Search Results

Year	Number of Results
2002	3
2003	3
2004	4
2005	1
2006	2
2007	2
2008	2
2009	2
2012	1
2018	1
2022	0

1

Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series.

Landry S, Chen CN, Patel N, Tseng A, Lalonde RG, Thibeault D, Sanche S, Sheehan NL. Landry S, et al. Among authors: lalonde rg. Antiviral Res. 2018 Apr;152:111-116. doi: 10.1016/j.antiviral.2018.02.010. Epub 2018 Feb 17. Antiviral Res. 2018. PMID: 29458132 Clinical Trial.

2

Laboratory-based risk factors for cytomegalovirus retinitis.

Hodge WG, Boivin JF, Shapiro SH, Lalonde RG, Shah KC, Murphy BD, Diaz-Mitoma F. Hodge WG, et al. Among authors: lalonde rg. Can J Ophthalmol. 2004 Dec;39(7):733-45. doi: 10.1016/s0008-4182(04)80067-x. Can J Ophthalmol. 2004. PMID: 15696763

3

The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients.

Sheehan NL, van Heeswijk RP, Foster BC, Akhtar H, Singhal N, Seguin I, DelBalso L, Bourbeau M, Chauhan BM, Boulassel MR, Burger DM, Lalonde RG, Cameron DW. Sheehan NL, et al. Among authors: lalonde rg. Molecules. 2012 Jan 12;17(1):688-702. doi: 10.3390/molecules17010688. Molecules. 2012. PMID: 22241465 Free PMC article. Clinical Trial.

4

Maraviroc for previously treated patients with R5 HIV-1 infection.

Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams. Gulick RM, et al. N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152. N Engl J Med. 2008. PMID: 18832244 Free PMC article. Clinical Trial.

5

Tuberculosis screening and active tuberculosis among HIV-infected persons in a Canadian tertiary care centre.

Brassard P, Hottes TS, Lalonde RG, Klein MB. Brassard P, et al. Among authors: lalonde rg. Can J Infect Dis Med Microbiol. 2009 Summer;20(2):51-7. doi: 10.1155/2009/658382. Can J Infect Dis Med Microbiol. 2009. PMID: 20514160 Free PMC article.

6

Clinical risk factors for cytomegalovirus retinitis in patients with AIDS.

Hodge WG, Boivin JF, Shapiro SH, Lalonde RG, Shah KC, Murphy BD, Dionne MA, Goela A. Hodge WG, et al. Among authors: lalonde rg. Ophthalmology. 2004 Jul;111(7):1326-33. doi: 10.1016/j.ophtha.2004.03.001. Ophthalmology. 2004. PMID: 15234132

7

Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

Lalonde RG, Boivin G, Deschênes J, Hodge WG, Hopkins JJ, Klein AH, Lindley JI, Phillips P, Shafran SD, Walmsley S. Lalonde RG, et al. Can J Infect Dis Med Microbiol. 2004 Nov;15(6):327-35. doi: 10.1155/2004/369390. Can J Infect Dis Med Microbiol. 2004. PMID: 18159510 Free PMC article.

8

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E; MOTIVATE 1 and MOTIVATE 2 Study Teams. Fätkenheuer G, et al. N Engl J Med. 2008 Oct 2;359(14):1442-55. doi: 10.1056/NEJMoa0803154. N Engl J Med. 2008. PMID: 18832245 Free article.

9

Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patients.

Gathe JC Jr, Pierone G, Piliero P, Arasteh K, Rubio R, Lalonde RG, Cooper D, Lazzarin A, Kohlbrenner VM, Dohnanyi C, Sabo J, Mayers D. Gathe JC Jr, et al. Among authors: lalonde rg. AIDS Res Hum Retroviruses. 2007 Feb;23(2):216-23. doi: 10.1089/aid.2006.0178. AIDS Res Hum Retroviruses. 2007. PMID: 17263650 Clinical Trial.

10

Virologic and immunologic response to a boosted double-protease inhibitor-based therapy in highly pretreated HIV-1-infected patients.

Smith GH, Boulassel MR, Klien M, Gilmore N, MacLeod J, LeBlanc R, René P, Routy JP, Lalonde RG. Smith GH, et al. Among authors: lalonde rg. HIV Clin Trials. 2005 Mar-Apr;6(2):63-72. doi: 10.1310/HAG3-8YA5-UDQC-36NX. HIV Clin Trials. 2005. PMID: 15983890 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results